EUVIMED · CrossrefZeitschrift
Therapeutic Advances in Rare Disease
ISSN 2633-0040 · SAGE Publications
Neueste Artikel
Eneboparatide induces prolonged 24-hour PTH 1 receptor activation
2000–2025: Emerging therapies in primary mitochondrial disease: A structured review, horizon scan, and roadmap for the future
Lysosomal storage diseases in North America: a comprehensive review of enzyme therapies and unmet needs
From roadmap to a sustainable end-to-end individualized therapy pathway
Roadmap to advance therapeutics for SYNGAP1 -related disorder: a patient organization perspective from SynGAP Research Fund
Establishing resources and increasing awareness to advance research on Dentatorubral-pallidoluysian atrophy toward a treatment: a patient organization perspective
Understanding dentatorubral-pallidoluysian atrophy (DRPLA) symptoms and impacts on daily life: a qualitative interview study with patients and caregivers
The growing research toolbox for SLC13A5 citrate transporter disorder: a rare disease with animal models, cell lines, an ongoing Natural History Study and an engaged patient advocacy organization
The small steps that lead to big impact: translating therapeutics from idea to reality for the CDKL5 deficiency disorder community
Emerging roles and opportunities for rare disease patient advocacy groups
Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review
Keratoconus: cross-linking the window of the eye
Therapeutic and diagnostic advances in Stickler syndrome
Introducing Therapeutic Advances in Rare Disease
Congenital cataract: a guide to genetic and clinical management
Role of red free imaging, retinal reflectance and fundus autofluorescence in Bietti crystalline dystrophy: case report
A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?
Conservative management of a fourth ventricular epidermoid in a patient with Gardner syndrome
Understanding the perspective of patients with pulmonary arterial hypertension: looking beyond health-related quality of life
Wiskott–Aldrich syndrome with normal platelet volume in a low-income setting: a case report
A challenging start but a bright future
IMPACT study: measuring the impact of caregiving on families and healthcare professionals of children and adults living with mucopolysaccharidoses in Ireland
They’ve been BITTEN: reports of institutional and provider betrayal and links with Ehlers-Danlos Syndrome patients’ current symptoms, unmet needs and healthcare expectations
Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review
New avenues for therapy in mitochondrial optic neuropathies
Utilizing telehealth to create a clinical model of care for patients with Batten disease and other rare diseases
Wolfram syndrome: new pathophysiological insights and therapeutic strategies
Improving patient informed consent for haemophilia gene therapy: the case for change
Marfan syndrome and the eye clinic: from diagnosis to management
Etranacogene dezaparvovec for hemophilia B gene therapy
EUVIMED